Giancarlo Marenzi

Summary

Affiliation: Centro Cardiologico Monzino
Country: Italy

Publications

  1. ncbi Contrast-induced nephropathy
    Giancarlo Marenzi
    Department of Cardiovascular Sciences, Centro Cardiologico Monzino, I R C C S, University of Milan, Via Parea 4, 20138, Milan, Italy
    Intern Emerg Med 7:181-3. 2012
  2. ncbi Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial
    Giancarlo Marenzi
    Centro Cardiologico Monzino, IRCCS, Department of Cardiovascular Sciences, University of Milan, Milan, Italy
    JACC Cardiovasc Interv 5:90-7. 2012
  3. ncbi Recent advances in the prevention of radiocontrast-induced nephropathy
    Giancarlo Marenzi
    Centro Cardiologico Monzino, IRCCS Institute of Cardiology of the University of Milan, Milan, Italy
    Curr Opin Crit Care 10:505-9. 2004
  4. ncbi Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score?
    Giancarlo Marenzi
    Intensive Cardiac Care Unit, Centro Cardiologico Monzino, Institute of Cardiology, University of Milan, Milan, Italy
    Nat Clin Pract Cardiovasc Med 2:80-1. 2005
  5. ncbi Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients
    Giancarlo Marenzi
    Centro Cardiologico Monzino, I R C C S, Institute of Cardiology of the University of Milan, Milan, Italy
    Am J Med 119:155-62. 2006
  6. ncbi Prophylactic hemodialysis for the prevention of contrast-induced nephropathy after coronary angiography
    Giancarlo Marenzi
    Intensive Cardiac Care Unit at the Centro Cardiologico Monzino, Istituti di Ricovero e Cura a Carattere Scientifico, Institute of Cardiology, University of Milan, Milan, Italy
    Nat Clin Pract Nephrol 4:130-1. 2008
  7. ncbi N-acetylcysteine and contrast-induced nephropathy in primary angioplasty
    Giancarlo Marenzi
    Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico, Institute of Cardiology, University of Milan, Milan, Italy
    N Engl J Med 354:2773-82. 2006
  8. ncbi [Management of renal complications during primary angioplasty]
    Giancarlo Marenzi
    Centro Cardiologico Monzino, I R C C S, Istituto di Cardiologia, Universita, Milano
    Recenti Prog Med 98:367-72. 2007
  9. ncbi Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission
    Giancarlo Marenzi
    Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico, Institute of Cardiology of the University of Milan, Milan, Italy
    Crit Care Med 38:438-44. 2010
  10. ncbi Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty
    Giancarlo Marenzi
    Centro Cardiologico Monzino, I R C C S, Institute of Cardiology, University of Milan, Milan, Italy
    Am Heart J 153:755-62. 2007

Collaborators

Detail Information

Publications41

  1. ncbi Contrast-induced nephropathy
    Giancarlo Marenzi
    Department of Cardiovascular Sciences, Centro Cardiologico Monzino, I R C C S, University of Milan, Via Parea 4, 20138, Milan, Italy
    Intern Emerg Med 7:181-3. 2012
    ..The purpose of this study is to examine the pathophysiology, risk factors and clinical course of CIN, as well as the most recent studies dealing with its prevention and potential therapeutic interventions, especially during PCI...
  2. ncbi Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial
    Giancarlo Marenzi
    Centro Cardiologico Monzino, IRCCS, Department of Cardiovascular Sciences, University of Milan, Milan, Italy
    JACC Cardiovasc Interv 5:90-7. 2012
    ..This study investigated the effect of furosemide-forced diuresis and intravenous saline infusion matched with urine output, using a novel dedicated device designed for contrast-induced nephropathy (CIN) prevention...
  3. ncbi Recent advances in the prevention of radiocontrast-induced nephropathy
    Giancarlo Marenzi
    Centro Cardiologico Monzino, IRCCS Institute of Cardiology of the University of Milan, Milan, Italy
    Curr Opin Crit Care 10:505-9. 2004
    ..This article reviews recent clinical researches concerning new developments in the prevention of radiocontrast nephropathy and analyzes unresolved issues...
  4. ncbi Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score?
    Giancarlo Marenzi
    Intensive Cardiac Care Unit, Centro Cardiologico Monzino, Institute of Cardiology, University of Milan, Milan, Italy
    Nat Clin Pract Cardiovasc Med 2:80-1. 2005
  5. ncbi Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients
    Giancarlo Marenzi
    Centro Cardiologico Monzino, I R C C S, Institute of Cardiology of the University of Milan, Milan, Italy
    Am J Med 119:155-62. 2006
    ..We assessed the mechanisms involved in the prophylactic effect of hemofiltration and of the most effective hemofiltration protocol to prevent contrast-induced nephropathy in patients with chronic kidney disease...
  6. ncbi Prophylactic hemodialysis for the prevention of contrast-induced nephropathy after coronary angiography
    Giancarlo Marenzi
    Intensive Cardiac Care Unit at the Centro Cardiologico Monzino, Istituti di Ricovero e Cura a Carattere Scientifico, Institute of Cardiology, University of Milan, Milan, Italy
    Nat Clin Pract Nephrol 4:130-1. 2008
  7. ncbi N-acetylcysteine and contrast-induced nephropathy in primary angioplasty
    Giancarlo Marenzi
    Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico, Institute of Cardiology, University of Milan, Milan, Italy
    N Engl J Med 354:2773-82. 2006
    ..We investigated the antioxidant N-acetylcysteine for the prevention of contrast-medium-induced nephropathy in patients undergoing primary angioplasty...
  8. ncbi [Management of renal complications during primary angioplasty]
    Giancarlo Marenzi
    Centro Cardiologico Monzino, I R C C S, Istituto di Cardiologia, Universita, Milano
    Recenti Prog Med 98:367-72. 2007
    ....
  9. ncbi Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission
    Giancarlo Marenzi
    Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico, Institute of Cardiology of the University of Milan, Milan, Italy
    Crit Care Med 38:438-44. 2010
    ..To evaluate the clinical and prognostic relevance of acute kidney injury (AKI) in the setting of ST-elevation acute myocardial infarction (STEMI) complicated by cardiogenic shock (CS)...
  10. ncbi Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty
    Giancarlo Marenzi
    Centro Cardiologico Monzino, I R C C S, Institute of Cardiology, University of Milan, Milan, Italy
    Am Heart J 153:755-62. 2007
    ....
  11. ncbi Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality
    Giancarlo Marenzi
    University of Milan, Milan, Italy
    Ann Intern Med 150:170-7. 2009
    ....
  12. ncbi Hemofiltration in heart failure
    G Marenzi
    Centro Cardiologico Monzino, IRCCS, Institute of Cardiology, University of Milan, Milan, Italy
    Int J Artif Organs 27:1070-6. 2004
    ..In this setting, hemofiltration, differently from diuretics, is able to remove the increased lung water content and to improve clinical condition, exercise capacity and lung function...
  13. ncbi Circulating cytochrome c as potential biomarker of impaired reperfusion in ST-segment elevation acute myocardial infarction
    Giancarlo Marenzi
    Centro Cardiologico Monzino, IRCCS, Department of Cardiovascular Sciences, University of Milan, Milan, Italy
    Am J Cardiol 106:1443-9. 2010
    ..20 to 2.20, vs 1.1 ng/ml, interquartile range 0.65 to 1.55; p = 0.04). In conclusion, serum cytochrome c is detectable in the early phase of STEMI treated with pPCI and is associated with clinical signs of impaired myocardial reperfusion...
  14. ncbi Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction
    Giancarlo Marenzi
    Centro Cardiologico Monzino, I R C C S, Institute of Cardiology of the University of Milan, Milan, Italy
    J Am Coll Cardiol 44:1780-5. 2004
    ..The aim of this research was to assess the incidence, clinical predictors, and outcome of contrast-induced nephropathy (CIN) after primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)...
  15. ncbi Hemofiltration in the prevention of radiocontrast agent induced nephropathy
    G Marenzi
    Monzino Heart Center, IRCCS, Institute of Cardiology, University of Milan, Milan, Italy
    Minerva Anestesiol 70:189-91. 2004
    ..The aim of the study was to investigate the role of hemofiltration in preventing contrast nephropathy in patients with renal failure...
  16. ncbi Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention
    Giancarlo Marenzi
    Department of Cardiovascular Sciences, Centro Cardiologico Monzino, I R C C S, University of Milan, Milan, Italy
    Am Heart J 160:1170-7. 2010
    ..We investigated the possible association between acute hyperglycemia and CIN in patients undergoing primary PCI...
  17. ncbi [Prevention of contrast-induced nephropathy and management of high-risk patients]
    Giancarlo Marenzi
    Centro Cardiologico Monzino, IRCCS, Istituto di Cardiologia, Universita degli Studi, Milano
    G Ital Cardiol (Rome) 10:88-96. 2009
    ....
  18. ncbi The prevention of radiocontrast-agent-induced nephropathy by hemofiltration
    Giancarlo Marenzi
    Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico, Institute of Cardiology, University of Milan, Milan, Italy
    N Engl J Med 349:1333-40. 2003
    ..We investigated the role of hemofiltration, as compared with isotonic-saline hydration, in preventing contrast-agent-induced nephropathy in patients with renal failure...
  19. ncbi Serum to urinary sodium concentration ratio is an estimate of plasma renin activity in congestive heart failure
    Giancarlo Marenzi
    Centro Cardiologico Monzino, IRCCS, Institute of Cardiology, University of Milan, Via Parea 4, 20138 Milan, Italy
    Eur J Heart Fail 4:597-603. 2002
    ..In CHF, the [sNa(+)]/[uNa(+)] ratio best correlates with PRA and reflects the basal activity as well as the rapid changes (as those induced by UF) of the RAS. Therefore, it can be considered a strong and easily available marker of PRA...
  20. ncbi Continuous veno-venous hemofiltration for the treatment of contrast-induced acute renal failure after percutaneous coronary interventions
    Giancarlo Marenzi
    Centro Cardiologico Monzino, IRCCS, Institute of Cardiology, University of Milan, Milan, Italy
    Catheter Cardiovasc Interv 58:59-64. 2003
    ..However, despite promising early results, large randomized trials are required to define the role of CVVH in ARF after PCI...
  21. ncbi Kinetics of plasma SPB and RAGE during mechanical ventilation in patients undergoing major vascular surgery
    Piergiuseppe Agostoni
    Centro Cardiologico Monzino, IRCCS, Milan, Italy
    Respir Physiol Neurobiol 178:256-60. 2011
    ..SPB(N) increase (T(END)-T0), but not RAGE(N), was related to ΔPaO(2)/FiO2 changes during mechanical ventilation (r=0.575, p=0.01). Plasma RAGE(N) and SPB(N) kinetics in patients undergoing major vascular surgery are different...
  22. ncbi Hyperoxemic perfusion of the left anterior descending coronary artery after primary angioplasty in anterior ST-elevation myocardial infarction
    Daniela Trabattoni
    Centro Cardiologico Monzino IRCCS, Institute of Cardiology, University of Milan, Milan, Italy
    Catheter Cardiovasc Interv 67:859-65. 2006
    ..Enzyme kinetic and ST-segment changes suggest faster and more complete microvascular reperfusion and may explain the salutary effects of this new therapy on left ventricular function...
  23. ncbi N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial
    Erminio Sisillo
    Anesthesia and Critical Care Unit, Centro Cardiologico Monzino, I R C C S, Institute of Cardiology, University of Milan, Milan, Italy
    Crit Care Med 36:81-6. 2008
    ..To assess the preventive effect of the antioxidant N-acetylcysteine on postoperative acute renal failure in patients with renal insufficiency undergoing cardiac surgery...
  24. ncbi Gas diffusion and alveolar-capillary unit in chronic heart failure
    Piergiuseppe Agostoni
    Centro Cardiologico Monzino, IRCCS, Istituto di Cardiologia, Universita di Milano, Via Parea 4, 20138 Milan, Italy
    Eur Heart J 27:2538-43. 2006
    ..Diffusion depends on membrane diffusion (DM) and the amount of blood participating in gas exchange (VC). How DM, VC, and the alveolar-capillary unit behave in relationship to CHF severity is unknown...
  25. ncbi Gene expression profiling reveals multiple differences in platelets from patients with stable angina or non-ST elevation acute coronary syndrome
    Gualtiero Colombo
    Centro Cardiologico Monzino IRCCS, Via Parea 4, Milan, Italy
    Thromb Res 128:161-8. 2011
    ....
  26. ncbi Circulating Levels of Dimethylarginines, Chronic Kidney Disease and Long-Term Clinical Outcome in Non-ST-Elevation Myocardial Infarction
    Viviana Cavalca
    Centro Cardiologico Monzino, I R C C S, Milan, Italy Dipartimento di Scienze Cliniche e di Comunità, Universita degli Studi di Milano, Milan, Italy
    PLoS ONE 7:e48499. 2012
    ..We measured plasma concentration of arginine, ADMA and SDMA and investigated their relationship with CKD and long-term outcome in non-ST-elevation myocardial infarction (NSTEMI)...
  27. ncbi Percutaneous cardiopulmonary support for catheter ablation of unstable ventricular arrhythmias in high-risk patients
    Corrado Carbucicchio
    Centro Cardiologico, Fondazione Monzino IRCCS, Institute of Cardiology, University of Milan, Milano, Italy
    Herz 34:545-52. 2009
    ..The use of the percutaneous cardiopulmonary support (CPS) for circulatory assistance may allow patient's stabilization and enhance efficacy and safety of CA in this emergency setting...
  28. ncbi Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study
    P Agostoni
    Centro Cardiologico Monzino, IRCCS, Dept of Cardiovascular Sciences, University of Milan, Milan, Italy
    Eur Respir J 37:841-7. 2011
    ..This behaviour was confirmed when RAGE and SPB were normalised for protein content. Parallel changes were observed for immature SPB. Plasma RAGE and SPBs are sensitive and rapid markers of lung distress...
  29. ncbi High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study
    Nicole Cristell
    Universita Vita Salute San Raffaele, Istituto Scientifico San Raffaele, Milan, Italy
    J Am Coll Cardiol 58:2654-61. 2011
    ..This study sought to assess the prevalence of normal levels of high sensitivity C-reactive protein (hsCRP) at the very onset of ST-segment elevation myocardial infarction (STEMI)...
  30. ncbi Proteome of platelets in patients with coronary artery disease
    Cristina Banfi
    Centro Cardiologico Monzino, I R C C S, Milan, Italy
    Exp Hematol 38:341-50. 2010
    ..This study aimed at investigating the protein patterns of platelets from patients with stable or acute coronary atherosclerosis (CAD), in which platelets play a key role...
  31. ncbi Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates
    Marta Brambilla
    Department of Pharmacological Sciences, University of Milan, Via Balzaretti, 9, 20133 Milan, Italy
    Arterioscler Thromb Vasc Biol 28:947-53. 2008
    ..The aim of this study was to investigate the expression of TF in PLA, in platelets, and in monocytes of acute coronary syndrome (ACS) patients compared to SA patients and healthy subjects (Controls)...
  32. ncbi Circadian distribution of acute myocardial infarction by anatomic location and coronary artery involvement
    Paolo Moruzzi
    Centro Cardiologico Monzino, I R C C S, Institute of Cardiology, University of Milan, Milan, Italy
    Am J Med 116:24-7. 2004
    ..Acute myocardial infarction follows a circadian pattern, with a morning peak ascribed to sympathetic activation. However, about 20% of myocardial infarctions occur between midnight and 6 AM; these events may have different characteristics...
  33. ncbi Pulmonary hemodynamic and tidal volume changes during exercise in heart failure
    Piergiuseppe Agostoni
    Institute of Cardiology, Centro Cardiologico Monzino, IRCCS, University of Milan, Centro di Studio per le Ricerche Cardiovascolari del Consiglio Nazionale delle Ricerche, Milan, Italy
    Ital Heart J 3:104-8. 2002
    ....
  34. ncbi Contrast-induced nephropathy
    Antonio L Bartorelli
    Centro Cardiologico Monzino IRCCS, Institute of Cardiology, University of Milan, Milan, Italy
    J Interv Cardiol 21:74-85. 2008
    ..The purpose of this article is to examine the pathophysiology, risk factors, and clinical course of CIN, as well as the most recent studies dealing with its prevention and potential therapeutic interventions, especially during PCI...
  35. ncbi Circulating microRNAs are new and sensitive biomarkers of myocardial infarction
    Yuri D'Alessandra
    Laboratorio di Biologia Vascolare e Medicina Rigenerativa, Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico IRCCS, Milan, Italy
    Eur Heart J 31:2765-73. 2010
    ..Circulating microRNAs (miRNAs) may represent a novel class of biomarkers; therefore, we examined whether acute myocardial infarction (MI) modulates miRNAs plasma levels in humans and mice...
  36. ncbi Cardiac and renal dysfunction in chronic heart failure: relation to neurohumoral activation and prognosis
    G Marenzi
    IRCCS, Institute of Cardiology, University of Milan, Italy
    Am J Med Sci 321:359-66. 2001
    ..We investigated the relationship between both cardiac and renal dysfunction and neurohumoral activation, and their possible influence on prognosis...
  37. ncbi Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure
    G Marenzi
    Centro Cardiologico Monzino, I R C C S, Institute of Cardiology, University of Milan, Milan, Italy
    J Am Coll Cardiol 38:963-8. 2001
    ..The goal of this study was to investigate the hemodynamic and circulatory adjustments to extracorporeal ultrafiltration (UF) in refractory congestive heart failure (rCHF)...
  38. ncbi Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure
    P G Agostoni
    Istituto di Cardiologia dell Universita degli Studi, Centro Cardiologico IRCCS, Centro di Studio per le Ricerche Cardiovascolari del CNR, Milan, Italy
    J Am Coll Cardiol 36:1600-4. 2000
    ..We sought to investigate the possibility that lung diffusing capacity reduction observed in chronic heart failure is reversible in the short term...
  39. ncbi [Extracorporeal treatment in patients with heart failure: pathophysiology, indications and results.]
    G Marenzi
    Centro Cardiologico Monzino, I.R.C.C.S, Istituto di Cardiologia, , Milano
    G Ital Nefrol 23:S46-51. 2006
    ..In this setting, ultrafiltration, unlike diuretics, can remove the increased lung water content and improve clinical condition, exercise capacity and lung function...
  40. ncbi Noninvasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation
    Piergiuseppe Agostoni
    J Am Coll Cardiol 46:1779-81. 2005
  41. ncbi Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial
    Giancarlo Marenzi
    Eur Heart J 28:2172-3; author reply 2173-4. 2007